Daiichi vitamin production
This article was originally published in The Tan Sheet
Executive Summary
Daiichi Fine Chemical has decided to stop production of vitamin B6 (pyridoxine HCl) at its Takaoka City, Japan facility effective July 31. Firm cites "poor global market conditions" as primary reason for exiting business. Following July closing date, Daiichi Pharmaceutical subsidiary will utilize facility to produce pharmaceutical intermediates and shift its focus to vitamin B5 (pantothenic acid) production. Firm manufactures 10 different forms of pantothenic acid for use in human nutrition, personal care and pharmaceutical products...